Amgen Inc. logo

Amgen Inc. (0R0T)

Market Closed
24 Dec, 15:30
LSE LSE
NASDAQ (NGS) NASDAQ (NGS) Primary XMIL XMIL XMIL XMIL XHAN XHAN XBER XBER XDUS XDUS XETRA XETRA XMUN XMUN XMEX XMEX XFRA XFRA XWBO XWBO
$
264. 50
+3
+1.15%
$
- Market Cap
19.61 P/E Ratio
1.28% Div Yield
692 Volume
18.58 Eps
$ 261.5
Previous Close
Day Range
261.6 264.5
Year Range
253.2 330.26
Earnings results expected in 30 days

Summary

0R0T closed today higher at $264.5, an increase of 1.15% from yesterday's close, completing a monthly increase of 0% or $0. Over the past 12 months, 0R0T stock gained 0%.
0R0T pays dividends to its shareholders, with the most recent payment made on Dec 09, 2024. The next announced payment will be in In 2 months on Mar 07, 2025 for a total of $2.38.
The last earnings report, released on Oct 30, 2024, exceeded the consensus estimates by 0.47%. On average, the company has fell short of earnings expectations by -1.51%, based on the last three reports. The next scheduled earnings report is due on Feb 04, 2025.
The stock of the company had never split.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on
  LSE (USD).
Want to track 0R0T and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free

0R0T Chart

FAQ

What Is the Amgen Inc.(0R0T) Stock Price Today?

The 0R0T stock price today is $264.50.

What Stock Exchange Does Amgen Inc. Trade On?

Amgen Inc. is listed and trades on the NASDAQ (NGS).

What Is the Stock Symbol for Amgen Inc.?

The stock symbol for Amgen Inc. is "0R0T".

Does Amgen Inc. Pay Dividends? What's The Current Dividend Yield?

Yes, Amgen Inc. pays dividends and the current yield is 1.28%.

What Is the Amgen Inc. Market Cap?

As of today, Amgen Inc. does not have a market cap available.

What is Amgen Inc. Earnings Per Share?

The Amgen Inc. EPS is 0.

What Is the Next Amgen Inc. Earnings Date?

Amgen Inc. will release its next earnings report on Feb 04, 2025.

Did Amgen Inc. had any splits?

No, Amgen Inc. has never had a stock split.

Amgen Inc. Profile

Drug Manufacturers - General Industry
Healthcare Sector
Mr. Robert A. Bradway CEO
LSE Exchange
US0311621009 ISIN
US Country
26,700 Employees
7 Mar 2025 Last Dividend
22 Nov 1999 Last Split
17 Jun 1983 IPO Date

Overview

Amgen Inc. is a global leader in biotechnology, focusing on the discovery, development, manufacture, and delivery of human therapeutics. The company has a comprehensive portfolio of treatment options targeting various diseases and conditions, ranging from oncology and osteoporosis to cardiovascular diseases and inflammatory disorders. Founded in 1980 and headquartered in Thousand Oaks, California, Amgen serves healthcare providers worldwide, including physicians' clinics, dialysis centers, hospitals, and pharmacies. Its distribution network encompasses pharmaceutical wholesale distributors and direct-to-consumer channels. Amgen’s collaborative efforts extend to several high-profile partnerships with other pharmaceutical giants, including AstraZeneca, Novartis Pharma AG, UCB, Kyowa Kirin Co., Ltd., and BeiGene, Ltd., aiming at the expansion and development of innovative therapies.

Products and Services

  • Enbrel - A leading therapy for plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis.
  • Otezla - Designed for adults suffering from plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease.
  • Prolia - Addresses osteoporosis in postmenopausal women.
  • XGEVA - Prevents skeletal-related events.
  • Repatha - Reduces the risk of myocardial infarction, stroke, and coronary revascularization.
  • Nplate - Treats immune thrombocytopenia.
  • KYPROLIS - For relapsed or refractory multiple myeloma patients.
  • Aranesp - Addresses a lower-than-normal number of red blood cells and anemia.
  • EVENITY - A treatment for osteoporosis in postmenopausal for men and women.
  • Vectibix - Treats patients with wild-type RAS metastatic colorectal cancer.
  • BLINCYTO - For patients with acute lymphoblastic leukemia.
  • TEPEZZA - Treats thyroid eye disease.
  • KRYSTEXXA - Addresses chronic refractory gout.
  • Additional Products - Amgen also markets Neulasta, MVASI, AMJEVITA/AMGEVITA, TEZSPIRE, Parsabiv, Aimovig, LUMAKRAS/LUMYKRAS, EPOGEN, KANJINTI, TAVNEOS, RAVICTI, UPLIZNA, and PROCYSBI, covering a wide range of therapeutic areas.

Contact Information

Address: One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799
Phone: 805 447 1000
Affiliate Program About Report a Bug Terms Privacy Help Contact Us
2025 © Marketlog. All Rights Reserved.
Play store app banner Play store app banner dark App store app banner App store app banner dark